Declare pilot implementation of major difficult disease of Chinese and western medicine clinical collaboration work notification

The 2015-12-18 15:59:18 reference: the department the author:

The traditional Chinese medicine for medical administration letter [2015] no. 258

Provinces, autonomous regions and municipalities directly under the central government health and family planning commission, the administration of traditional Chinese medicine, the xinjiang production and construction corps health bureau:

To carry out the \"equal emphasis on Chinese and western medicine\" health work policy, exploration of prevention and treatment of diseases with traditional Chinese and western new ideas, new methods and new patterns, according to the state council about support and promote the development of the cause of Chinese medicine several opinions (guo fa [2009] no. 22) the ministry of health, the state administration of traditional Chinese medicine, the health \"about the opinions of the strengthen conscientiously the work of general hospital of traditional Chinese medicine\" (the country is sent [2008] no. 14) of traditional Chinese medicine of the general hospital of traditional Chinese medicine work guide \"(the traditional Chinese medicine medical ZhengFa [2011] no. 14) and the implementation of general hospital of traditional Chinese medicine special efforts to promote action notice (the traditional Chinese medicine for the medical ZhengFa [2014] 38) file spirit, such as the state administration of traditional Chinese medicine with national health and family planning commission decided to jointly carry out major refractory disease of Chinese and western medicine clinical trial collaboration to declare work, will now matters related to notice the following:

First, the guiding ideology

Conscientiously implement the party's \"equal emphasis on Chinese and western medicine\" health work policy, fully learn from two medical advantages of traditional Chinese medicine, western medicine, and mutual fusion, promote each other, complement each other, by means of combining traditional Chinese and western medicine and methods for prevention and control of diseases and promote health, improve the health service ability and the comprehensive level of medical treatment, ensure life safety and health for the people.

Second, the pilot target

Around the doctor of traditional Chinese medicine diagnosis and treatment has the advantage of major diseases and difficult diseases and infectious diseases, the key specialty of traditional Chinese medicine hospital combined key specialty and advantage of general hospital in related disciplines to form of Chinese and western medicine clinical group, in accordance with the \"integrate resources and have complementary advantages, combination, collaborative research, integration of Chinese and western, improve the curative effect of\" principle, combined Chinese and western medicine research conducted by three years, and in order to improve the clinical curative effect for the purpose, in the clinical practice of Chinese and western medicine combined with industry experts, formed on the basis of consensus in the diagnosis and treatment plan, to explore the establishment of long-term mechanism and mode of Chinese and western medicine clinical collaboration.

Third, a collaboration scope

Around the following major refractory disease, emergency and severe cases in Chinese and western medicine clinical collaboration:

(a) cancer: lung, stomach, liver, colorectal cancer, breast cancer

(2) blood disease, children with acute leukemia, aplastic anemia, chronic myelogenous leukemia

(3) infectious diseases: multidrug-resistant tuberculosis, AIDS, chronic liver failure

(4) mental illness: major depressive disorder

(5) the respiratory system: pulmonary fibrosis, chronic obstructive pulmonary disease (copd)

(6) the circulatory system: chronic congestive heart failure, angina pectoris after acute myocardial infarction, coronary reascularization, refractory hypertension

(7) the nervous system, cerebral infarction, alzheimer's disease, alzheimer's disease), Parkinson's disease

(eight) rheumatoid immune system: rheumatoid arthritis and systemic lupus erythematosus (sle)

(9) : endocrine system, JiaJian, hyperthyroidism diabetes and complication

(10) of the digestive system: ulcerative colitis, liver fibrosis

Chronic renal failure (11) : the urinary system

(12) : other joint degenerative diseases, infertility, optic neuropathy

Fourth, cooperation content

(a) the construction of major difficult disease of Chinese and western medicine clinical collaboration platform, promote the standardization of service mode. Give full play to respectively characteristics and advantages of traditional Chinese medicine, western medicine, from clinical, in view of the major difficulty and infectious disease at some stage in the process of occurrence and development, the key link, mining consolidation treatment experience and the characteristics of traditional Chinese medicine therapy, combine traditional Chinese and western medicine clinical collaboration, form a unique combination of Chinese and western medicine diagnosis and treatment plan.

Major refractory disease (2) the innovation of traditional Chinese and western medicine clinical collaboration mechanism, promotion mechanism institutionalization. Clinical diagnosis and treatment of traditional Chinese medicine group and western medicine in clinical diagnosis and treatment to create interactive mechanism of teamwork that diagnosis and treatment, the establishment of Chinese and western medicine personnel closely collaborative diagnosis, joint consultation, joint operation, joint case discussions, academic association, traditional Chinese and western medicine department head cross office cooperation mode and medical system, one-stop services, collaborative integrated traditional Chinese and western medicine diagnosis and treatment for patients improve the ability of handling treatment difficulty.

(3) establish a major difficulty disease clinical cooperation of Chinese and western medicine efficacy evaluation system, promote the cooperation achievements gradually popularization and application. Combination of TCM and western medicine therapy and clinical implementation of dynamic management, strengthen the analysis of clinical data, summary and evaluation, to explore, disease combined with traditional Chinese medicine and western medicine major of incurable disease clinical curative effect evaluation method and evaluation standard, form the cooperation of Chinese and western medicine to prevent and control major refractory disease technology center and application platform; Formation based on evidence-based medicine research, and long-term follow-up and long-term follow-up evaluation mechanism and mode.

(4) to explore the major difficulty disease a new way of cooperation of Chinese and western medicine personnel training, implement staff long work state. Research to develop in the western, middle west cross training system of Chinese and western medicine, to carry out the talents of Chinese and western medicine clinical practice dialogue, clear major refractory disease of traditional Chinese and western medicine personnel work responsibilities and tasks, formed with a fusion of Chinese and western medicine thought team cooperation of Chinese and western medicine diagnosis and treatment.

(5) the major difficulty disease law of development, promote development of combined Chinese and western medicine. Play their respective advantages of traditional Chinese and western medicine, adhere to the people-centered concept, multidisciplinary and comprehensive cooperation, the formation of medical treatment, teaching, scientific research, the combination of from the prevention, treatment, to the rehabilitation of the cooperation of Chinese and western medicine to prevent and control major refractory disease diagnosis and treatment system.

Five, the basic conditions

(a) on the hospital of traditional Chinese medicine (TCM) for level 3 hospital (including combine traditional Chinese and western medicine hospital, national medical hospital, similarly hereinafter) or 3 (specialized subject, similarly hereinafter) hospital, 3 maternal and child health care.

(2) the specialized subject of selected major refractory disease with a unique and advantage of diagnosis and treatment, the clinical curative effect is distinct, the leading level in domestic modern medicine or Chinese medicine field.

(3) the specialized subject is stable, reasonable structure of talent echelon, disciplinary leaders engaged in professional and declare disease to agree, and in the field of the major domestic authoritative academic status.

(4) the specialized subject above for nearly three years without secondary medical accident.

Six, according to the procedures and requirements

(a) quota allocation

Provinces, autonomous regions and municipalities directly under the central government in strict accordance with the quota allocation (see appendix 1) declared major refractory disease of Chinese and western medicine clinical collaboration, pilot project declaration amount shall not be higher than the quota allocation, temporarily not qualified province don't declare, appoint, bureau directly under the declaration (tube), based on the principles of ShuDeHua hospital. Each disease led by 1 doctor of traditional Chinese medicine hospitals, in principle joint 1 general hospital or health care of women and children's joint declaration. Each medical institutions to take the lead of Chinese and western medicine clinical collaboration to declare (diseases) only one pilot projects.

(2) according to the procedures

1. Eligible medical institutions in accordance with the relevant requirements and their own practice, combine the major difficult disease of Chinese and western medicine clinical cooperation pilot project, the project filing materials by led declaration form in January 8, 2016 to submit the provincial administrative department of traditional Chinese medicine.

2. The joint family planning administrative department of public health at the provincial level provincial administrative department of traditional Chinese medicine after a review of project application materials, the traditional Chinese and western medicine clinical trial collaboration disease name, a list of the led units and cooperative unit (more than 1 please sort of project application, and affix one's seal) and written materials of project application, 7 copies and electronic materials in the state administration of traditional Chinese medicine on January 15, 2016.

3. The state administration of traditional Chinese medicine with national health and family planning commission jointly organized experts to the provinces, autonomous regions and municipalities directly under the declaration materials for review, and determine the major difficulty disease according to the results of the review of Chinese and western medicine clinical collaboration unit of pilot projects.

Seven, contact and contact way

Touch: the state administration of traditional Chinese medicine department combine traditional Chinese and western medicine and national medicine The king of jin

Address: dongcheng district of Beijing workers stadium west road no. 1

Mail editor: 100027

Tel: 010-59957686

The true: 010-59957694

E-mail: yzszxmz@126.com

Touch: national health and family planning commission medical hospital authority Man Po cheung

Address: Beijing xicheng district outside xizhimen south road no. 1 zip code: 100044

Contact phone: 010-68792730 preach true: 010-68792206

E-mail: YLYHLC@126.com

Attachment 1: major refractory disease of Chinese and western medicine clinical collaboration pilot project quota allocation table. Docx

The file type: docx b4591a871f086db00f407785a1a45a43. Docx (15.17 KB)

Attachment 2: major refractory disease of Chinese and western medicine clinical collaboration pilot project declaration. Doc

The file type: doc (195.00 KB) is 5254104 e7c1148ba55f04c86adf7d1ea doc.

General office of national health and family planning commission The state administration of traditional Chinese medicine office

On December 1, 2015